Found: 4
Select item for more details and to access through your institution.
Partial Response to Platinum Doublets in Refractory EGFR-Positive Non-Small Cell Lung Cancer Patients after RRx-001: Evidence of Episensitization.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
RRx-001-Induced Tumor Necrosis and Immune Cell Infiltration in an EGFR Mutation-Positive NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors: A Case Report.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Dysphonia after Bevacizumab Rechallenge: A Case Report.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Flushing Out Carcinoid Syndrome: Beneficial Effect of the Anticancer Epigenetic Agent RRx-001 in a Patient with a Treatment-Refractory Neuroendocrine Tumor.
- Published in:
- Case Reports in Oncology, 2015, v. 8, n. 3, p. 461, doi. 10.1159/000441775
- By:
- Publication type:
- Article